Kairali Exports

Kairali Exports is an Indian pharmaceutical exporter specializing in finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established in 2000, the company is headquartered in Thiruvananthapuram, Kerala. It operates as a proprietary firm, classified as a micro enterprise under the MSME Act for the financial year 2023-24. The company's Corporate Identification Number (CIN) is UDYAM-KL-12-0015376. Specific details regarding revenue, employee count, and website are not publicly disclosed.

Kairali Exports operates manufacturing facilities in Thiruvananthapuram, Kerala. The company specializes in the production of Ayurvedic and herbal pharmaceutical formulations, focusing on finished products such as tablets, capsules, syrups, and injections. Specific details regarding plant capacities and certifications are not publicly available.

The leadership team of Kairali Exports includes:

• Mr. Ayurvastra: Proprietor

• Mr. Kokki Kumar: CEO

Kairali Exports has a presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has engaged in export activities to these regions, with shipments recorded to countries such as the United States, Italy, and Poland. However, specific details regarding regulatory filings, approvals, and market access status in these countries are not publicly disclosed.

Kairali Exports has expanded its reach to emerging markets in Africa, Latin America, and Southeast Asia. The company has engaged in export activities to countries such as Ghana, Senegal, Ivory Coast, Guinea Bissau, and Nigeria. Specific details regarding WHO prequalification or other certifications enabling access to these markets are not publicly available.

Kairali Exports demonstrates a diversified geographic strategy, exporting to a range of countries across the Middle East, Europe, and Africa. This diversification helps mitigate concentration risk and indicates a strategic direction focused on expanding its global footprint. However, specific strategic initiatives or future outlooks are not publicly disclosed.

Specific details regarding Kairali Exports' FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. The company's export activities to the United States suggest some level of compliance with FDA regulations, but detailed information is not disclosed.

Specific details regarding Kairali Exports' WHO prequalification, EU Good Manufacturing Practice (GMP) certificates, or European Directorate for the Quality of Medicines & HealthCare (EDQM) status are not publicly available. The company's export activities to various countries indicate adherence to international quality standards, but detailed certifications are not disclosed.

Specific details regarding Kairali Exports' Central Drugs Standard Control Organisation (CDSCO) manufacturing licenses, state drug controller approvals, or export No Objection Certificates (NOCs) are not publicly available. The company's operations in India suggest compliance with national regulatory requirements, but detailed information is not disclosed.

There are no publicly available records of Form 483 observations, warning letters, or import alerts issued to Kairali Exports. The absence of such records suggests a clean regulatory history, but detailed information is not disclosed.

Kairali Exports operates in the Ayurvedic and herbal pharmaceutical sector, competing with other Indian exporters in this niche market. While specific competitors and market share comparisons are not publicly disclosed, the company's focus on finished pharmaceutical formulations positions it within a competitive landscape that includes both domestic and international players.

Kairali Exports' specialization in Ayurvedic and herbal pharmaceutical formulations, particularly finished products such as tablets, capsules, syrups, and injections, distinguishes it in the market. The company's diversified export destinations across the Middle East, Europe, and Africa further enhance its competitive advantage.

Kairali Exports' current strategic direction appears to focus on expanding its global footprint through diversified export activities. The company's engagement in both regulated and emerging markets indicates a balanced approach to growth. However, specific strategic initiatives or future outlooks are not publicly disclosed.

Kairali Exports has a track record of exporting a range of pharmaceutical products, including Ayurvedic and herbal formulations, to various international markets. The company's export volume and consistency suggest reliability as a supplier. However, specific indicators of reliability, such as customer feedback or quality certifications, are not publicly available.

Importers should verify the following certifications when considering Kairali Exports as a supplier:

• FDA Registration: To ensure compliance with U.S. regulations. Verification can be done through the FDA's official website.

• WHO-GMP Certification: To confirm adherence to international manufacturing standards. Verification can be done through the World Health Organization's official website.

• EU GMP Certification: To ensure compliance with European manufacturing standards. Verification can be done through the European Medicines Agency's official website.

• ISO Certification: To confirm quality management systems. Verification can be done through the International Organization for Standardization's official website.

When conducting due diligence on Kairali Exports, consider the following steps:

• Verify Certifications: Ensure the company holds relevant certifications such as FDA registration, WHO-GMP, EU GMP, and ISO.

• Assess Financial Stability: Review financial statements and credit reports to evaluate the company's financial health.

• Evaluate Product Quality: Request product samples and assess quality through independent testing.

• Check Regulatory Compliance: Confirm compliance with relevant regulatory bodies in target markets.

• Review Export History: Analyze the company's export records to assess consistency and reliability.

Red flags to watch for include a lack of verifiable certifications, inconsistent financial records, poor product quality, and a history of regulatory violations.